Authors: GILES FJ KUSUANCO D LYNOTT A SHAH PM WANG LX SUPANDIMAN I POOVALINGAM V RANA F AZIZ F CHEN YC DUTOIT PJ JANUSZEWICZ H TEE GY WOLF M SUMANTRI R ALOMARI K TIAN D BEZWODA WR ABDI E GONZAGA M FAHED F FOURIE LS RUFF P POOL R KIM HC PARIKH PM KIM KY HO BS TAN P LEE SN TIEN SL WIJONO A LOBERIZA S LEE GH KIM SY HO CH BAYLON H AHN MJ THOMAS M WOLF M TIEN HF AYDOGDU I TAM J LIM SW CAVILEZ A

Citation: Fj. Giles et al., PROGNOSTIC FACTORS IN PATIENTS WITH PH-PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML) ENROLLED IN THE INTERNATIONAL ONCOLOGY STUDY-GROUP (IOSG) CML1 STUDY( EARLY CHRONIC), British Journal of Haematology, 102(1), 1998, pp. 187-187

Authors: ALGAZI M ANCELLEPARK R ASJO B BARIN F BARME M BARRESINOUSSI F BAYLON H BENICHOU J BENICHOU G BEZEAUD A BLANCHER A BLATTNER WA BLOT P BOURROUILLOU G BOUTTIER D BOVEN B BRUNET JB CADROY Y CAEN J CAHAN C CALVAS P CARANOBE C CARRELL RW CHANZY M CHAOUAT G CHIODI F COLOMBIES P COUTINHO A DAUSSET J DEVINCENTI I DEBRE P DENIS F DESMYTER J DEUBEL V DEVERGIE A DODIN A DORE JF DREYFUS JC DREYFUSBRISAC C DUCOS J DURAND H FENYO EM FLEURY H FOURNEL JJ FROTTIER J GAILLARD J GALANAUD P GARCON P GAZZOLO L GEORGES AJ GEORGESCOURBOT MC GIRARD M GLUCKMAN E GLUCKMAN JC GOLDBERG M GOUBAU P GUILLIN MC HERRAULT A JENNINGS M JUHANVAGUE I KANKI PJ KAZATCHKINE M KIRN A KLATZMANN D KOHEN JP KREIS H KRUH J LEMINOR L LESOURD G LIDEREAU R LORTHOLARY P LOWENSTEIN W LOYGUE J MARCOVICH H MARTY M MATHIOT C MONODBROCA P ORTH G DASILVA LP PERES G PILLOT J POLICARD C REYNES J ROZENBAUM W SCARLATTI G SCHAISON G SCHUPBACH J SIE P SMILOVICI W SOURNIA JC TARANTOLA D TAVITIAN A TEDGUI A TESTAS P TIOLLAIS P ULLMAN A WOLLMAN E WOLLMAN A

Citation: M. Algazi et al., APPEAL TO MITTERRAND IN BLOOD SCANDAL, Nature, 367(6461), 1994, pp. 312-312

Authors: BAYLON H

Citation: H. Baylon, COSTE,JEAN,FRANCOIS, Bulletin de l'Academie nationale de medecine, 176(9), 1992, pp. 1455-1463